The shift from injectable GLP-1 medications to oral pills presents a significant opportunity to improve diabetes and obesity treatment accessibility, particularly in the Global South. This change could reduce costs and logistical barriers associated with refrigeration and distri…
Researchers at the Weizmann Institute of Science have identified the protein MTCH2, which plays a critical role in determining whether cells burn fat or store it. Disabling this p…
A recent Phase 3 trial of the experimental obesity medication retatrutide demonstrated an average weight loss of 25% at the highest dose over 80 weeks, along with improvements in…
Eli Lilly's experimental obesity treatment, combining eloralintide and Mounjaro, has demonstrated an average weight loss of 23% in individuals with diabetes, highlighting its pote…
Recent developments in weight-loss medications highlight the potential of amylin-based drugs, which may offer effective weight management with fewer gastrointestinal side effects…
Recent clinical trial data reveals that Retatrutide, a new obesity treatment, resulted in an average weight loss of 25% after 80 weeks and 30% after 104 weeks among participants.…
A recent study has uncovered the first known function of a previously understudied brain region that plays a crucial role in regulating metabolism and the body's response to cold…
As prescriptions for GLP-1 medications surge among adolescents, parents face important considerations regarding their children's health. This article explores the benefits and pot…
A recent study indicates that tirzepatide, a treatment for obesity, may enhance metabolism by activating brown adipose tissue in obese mice. This finding could lead to new insight…
Roche has reported promising results from its mid-stage trial of enicepatide, an obesity drug that helped patients with type 2 diabetes achieve an average weight loss of 15.5% and…
The article examines the adherence challenges faced by individuals using GLP-1 medications for obesity treatment, highlighting factors beyond cost and side effects. It discusses i…
A new Scientific Statement from the Endocrine Society underscores the importance of focusing on health improvements rather than solely on weight loss in obesity treatment. The sta…